Asensus Surgical Provides Corporate Update
RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2023 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, is providing this corporate update in conjunction with its previously announced Investor Day, which will be hosted today, beginning at 11:30am EST.
Related news for (ASXC)
- asensus surgical announces closing of acquisition by karl storz
- Asensus Surgical to Participate in the H.C. Wainwright In-Person BioConnect Investor Conference
- Asensus Surgical to Participate in the Oppenheimer 33rd Annual Healthcare Conference
- Asensus and KARL STORZ to Market the Intelligent Surgical Unit and Co-Develop New Vision and Instrument Platforms